Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
about
Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysisRetrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-AnalysisEvidence and knowledge gaps on the disease burden in sexual and gender minorities: a review of systematic reviewsCost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling TechniquesThe prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysisInjecting drug use: A vector for the introduction of new hepatitis C virus genotypesHepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and preventionThe role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countriesVertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in SwitzerlandAre the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in EuropeState of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationRoutine testing for blood-borne viruses in prisons: a systematic reviewEpidemiology of Substance Use among Forced Migrants: A Global Systematic ReviewWidespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with menVaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection.Overview and recent trends of systematic reviews and meta-analyses in hepatology.Lower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire.Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries.Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.A Systematic Review and Meta-analysis of Psychosocial Interventions to Reduce Drug and Sexual Blood Borne Virus Risk Behaviours Among People Who Inject DrugsChronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study.HCV infected prisoners: should they be still considered a difficult to treat population?Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe.Hepatitis C virus seroprevalence in the general female population from 8 countriesIdentification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey.The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities.Undocumented migrant women in Denmark have inadequate access to pregnancy screening and have a higher prevalence Hepatitis B virus infection compared to documented migrants in Denmark: a prevalence study.Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countriesEfficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China.Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil.Factors influencing immunologic response to hepatitis B vaccine in adultsWorld-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.Cost-effectiveness of screening for hepatitis C virus: a systematic review of economic evaluations.Trends in the Incidence Rates of Chronic Hepatitis B in Poland in the Years 2005 - 2013.Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice
P2860
Q24186878-15846DCC-A1B4-4F36-AA36-0280897A4A1BQ24658656-33B4A5F8-383C-4426-ADB9-1ED0D3FC6A73Q26745887-A798CC4F-0FFD-4621-BC66-C41819595623Q26769600-3286FE55-F35B-4B66-A421-DE4E0F00F068Q26774500-679F81EA-0B9C-4DFE-BAC3-9DF3843B27E2Q26781853-6513C7BA-A2B1-45DF-8F97-5765D6DC575AQ26781991-DE1E6435-9FE6-4931-B48B-5E4871331820Q27014761-DD6AF431-38F9-47E2-8CE9-DDF009BFBF21Q28069369-A2A0C2AF-6164-40B6-97B6-1A75ACDADA96Q28069449-A1F2C19A-1BAD-4E17-8A22-BDDF8C3A2DCBQ28069741-C6057470-0E23-43C6-806E-C9FEF0240BADQ28079102-DED5F3FB-DB05-406F-A397-56460EE1823DQ28083198-CFA45743-54F7-4C02-B6D1-89EC8894589BQ28384052-5AF14962-85FB-4CF6-BCC0-8B3FD1B8104BQ28601393-F8157CDD-7058-4875-9D83-AF150C275511Q30236041-F54ED19D-FF28-4B6A-BC2F-D689E16A65C6Q30244767-DA5D2DD7-0DA3-485B-AF50-49C98D3131ECQ30434752-E5919238-0EDA-4C01-B0D5-4C68A5FA1749Q33678323-36DEDEAA-208E-4222-8BB9-3F15225F9460Q33726797-A23D76E6-CE9C-432C-A6FF-FA324719C934Q33802414-F55E2DC3-9D62-4F99-80C9-27C0B594FBDAQ33854811-2ACF629F-6D5E-47C4-8AEC-363A5BE9ED35Q34137291-5B77090D-5034-4100-BC27-4AA87AE65449Q34260649-AE49511B-0123-406F-A858-FE0583B22880Q34669256-982CFA4F-7C3A-4FE9-8547-99EDA798394AQ34941459-2A8E1AC2-ED93-4BB1-B7BA-6A3100FC1E5FQ35275203-1DA762FA-A747-4470-85E7-9FEF184193C5Q35738763-C6533704-4881-486C-91E9-C44985126A30Q35749620-45332893-C3B9-4F81-BE2F-0BE8318CCAF9Q35767961-331D7D42-B744-4D23-9FC1-DB78418E2FFBQ35927057-D933B2C4-0D8C-4158-A7CB-0BFE2E8F3D4FQ36027364-E25E17EE-6352-4683-8FA4-D122ED9C6AF3Q36285699-26E26E69-FB99-4DD7-ACF8-E3A9CDB5691FQ36705583-DB2FD97E-780F-4CE5-8C74-63D5EB0AD465Q36793870-EDCD12CD-07B5-4414-9A62-241F9ECAF69EQ37023727-7F160015-AB68-4F1E-AA4A-3F8B610560A3Q37248638-2717E91A-8205-45BB-A709-0CE2B79F3F66Q37251861-FAB0EA5A-20E8-48E3-926C-420FD0848912Q37358976-629FA559-969D-4597-9D2E-EC3B9636E473Q37402451-E0071269-325B-4565-9A04-4F08D4E2830D
P2860
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Infection with hepatitis B and ...... st-effectiveness of screening.
@ast
Infection with hepatitis B and ...... st-effectiveness of screening.
@en
Infection with hepatitis B and ...... st-effectiveness of screening.
@nl
type
label
Infection with hepatitis B and ...... st-effectiveness of screening.
@ast
Infection with hepatitis B and ...... st-effectiveness of screening.
@en
Infection with hepatitis B and ...... st-effectiveness of screening.
@nl
prefLabel
Infection with hepatitis B and ...... st-effectiveness of screening.
@ast
Infection with hepatitis B and ...... st-effectiveness of screening.
@en
Infection with hepatitis B and ...... st-effectiveness of screening.
@nl
P2093
P2860
P356
P1476
Infection with hepatitis B and ...... st-effectiveness of screening.
@en
P2093
Irene K Veldhuijzen
Lucas Wiessing
Marita van de Laar
Mika Salminen
Susan J M Hahné
Tek-Ang Lim
P2860
P2888
P356
10.1186/1471-2334-13-181
P5008
P577
2013-04-18T00:00:00Z
P5875
P6179
1005647008